HIGHLIGHTS
- who: Fengting Su from the Shenzhen Key Laboratory of Systemic Aging and Intervention (SAI), National Engineering Research Center for Biotechnology (Shenzhen), International Cancer Center, Shenzhen University, Shenzhen, China have published the paper: SIRT7-SREBP1 restrains cancer cell metabolic reprogramming by upregulating IDH1, in the Journal: (JOURNAL)
- what: The authors aimed to identify downstream targets of to help delineate its precise function. The authors demonstrate that is essential to regulate expression in various cancer cell types. The authors aimed to understand the roles of SIRT7 in regulation of tumor associated metabolism reprogramming. Considering that IDH1 expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.